ABVC BioPharma amends bylaws to reduce shareholder quorum to 33-1/3%

ABVC BIOPHARMA, INC.

Board approved amendment to Section 2.8 of Bylaws on March 14, 2024.
Quorum requirement lowered from a majority to 33-1/3% of votes entitled to be cast.
Amendment effective immediately as of March 14, 2024.
Exhibit 3.2 (Amendment to Bylaws) filed with the SEC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ABVC BIOPHARMA, INC.: Amended Section 2.8 of Bylaws to reduce shareholder meeting quorum from a majority to 33-1/3% of votes entitled to be cast (effective 2024-03-14).

Change: bylaw amendment
Effective: 2024-03-14

Exact text from the filing

the Board approved to amend Section 2.8 of the Company’s Bylaws to revise the number of shares needed to establish a quorum at shareholder meetings (the “Amendment”). The Amendment changes the quorum requirement from a majority to 33-1/3% of the votes entitled to be cast on a matter. The Amendment is effective as of March 14, 2024.

View on SEC.gov

Browse all governance changes →

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-022451

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.